Gopten

Gopten is a prescription medication that contains the active ingredient trandolapril, an angiotensin‑converting enzyme (ACE) inhibitor. It is administered orally and is marketed in the European Union. Trandolapril works by interfering with the renin‑angiotensin system, helping to lower blood pressure and reduce strain on the heart. Gopten is used under medical supervision for specific cardiovascular conditions.

Gopten is indicated for several cardiovascular and renal conditions where ACE inhibition is beneficial.

- Management of hypertension to achieve target blood pressure levels. - Treatment of chronic heart failure to improve symptoms and functional capacity. - Adjunct therapy in diabetic nephropathy to slow progression of kidney damage. - Post‑myocardial infarction therapy to reduce remodeling risk. - Use in combination with other antihypertensives when monotherapy is insufficient.

Trandolapril may cause a range of side effects, some of which are more frequently observed than others.

Common: - Cough, often dry and persistent. - Dizziness or light‑headedness, especially after standing. - Headache of mild to moderate intensity. - Fatigue or general weakness. - Elevated blood potassium levels (hyperkalaemia). - Reduced kidney function markers in laboratory tests.

Serious: - Angioedema presenting as facial, lip, tongue or throat swelling. - Severe hypotension leading to fainting or shock. - Acute kidney injury with rapid rise in serum creatinine. - Persistent high potassium levels causing cardiac arrhythmias. - Hepatic dysfunction with jaundice or abnormal liver enzymes. - Allergic skin reactions such as Stevens‑Johnson syndrome.

Before starting Gopten, certain health factors should be evaluated to ensure safe use.

- Assess renal function; dose adjustment may be required in impairment. - Monitor serum potassium, especially in patients on potassium‑sparing diuretics. - Use with caution in patients with a history of angioedema or hereditary angioedema. - Avoid use during the second and third trimesters of pregnancy (Category D). - Evaluate for hypotension risk in volume‑depleted individuals. - Review concomitant use of NSAIDs, which may affect kidney function. - Conduct regular blood pressure checks to avoid excessive lowering.

Trandolapril can interact with several drug classes, influencing its efficacy and safety profile.

Avoid: - Concurrent use with aliskiren in diabetic patients due to increased renal risk. - Combination with other ACE inhibitors or ARBs, which may cause additive hypotension. - Use with lithium, as trandolapril can raise lithium levels and toxicity.

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may impair renal function. - Potassium‑sparing diuretics or supplements, increasing hyperkalaemia risk. - Diuretics that may potentiate hypotensive effects. - Antihyperglycemic agents, as blood pressure changes can affect glucose control.